Brief: TRACON Pharmaceuticals Receives Notice Of Delisting From Nasdaq
30/12/2022 22:05
Dec 30 (Reuters) - TRACON Pharmaceuticals Inc TCON.O :
* TRACON PHARMACEUTICALS-ON DEC 30, 2022, CO RECEIVED NOTICE
OF
DELISTING/FAILURE TO SATISFY CONTINUED LISTING RULE; TRANSFER OF
LISTING FROM NASDAQ
Source: (https://bit.ly/3G5sliv)
Further company coverage: TCON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TRACON Pharmaceuticals
See all newsBrief: TRACON Pharmaceuticals Says ENVASARC Trial ORR Is 5%, Does Not Meet 11% Endpoint
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants